Financial Results - Standalone (Quarter Ended 30th June, 2026)

  • Revenue from Operations: ₹4,230.94 lakhs (compared to ₹2,803.07 lakhs in Q4 FY26 and ₹2,917.64 lakhs in Q1 FY25)
  • Other Income: ₹41.85 lakhs
  • Total Income: ₹4,272.79 lakhs
  • Total Expenses: ₹4,073.44 lakhs
  • Profit before Exceptional Items and Taxes: ₹199.35 lakhs (compared to loss of ₹688.99 lakhs in Q4 FY26)
  • Exceptional Items: Nil for current quarter (₹2,301.44 lakhs in Q4 FY26)
  • Profit before Tax: ₹199.35 lakhs
  • Tax Expense: Deferred tax credit of ₹10.68 lakhs
  • Net Profit after Tax: ₹210.03 lakhs
  • Total Comprehensive Income: ₹210.03 lakhs
  • Basic and diluted EPS: ₹0.58 (not annualized)
  • Paid-up Equity Share Capital: ₹3,615.27 lakhs (face value ₹10 each)

Financial Results - Consolidated (Quarter Ended 30th June, 2026)

  • Revenue from Operations: ₹4,230.94 lakhs
  • Other Income: ₹41.85 lakhs
  • Total Income: ₹4,272.79 lakhs
  • Total Expenses: ₹4,077.99 lakhs
  • Profit before Exceptional Items and Taxes: ₹194.80 lakhs
  • Exceptional Items: Nil
  • Profit before Tax: ₹194.80 lakhs
  • Tax Expense: Deferred tax credit of ₹9.86 lakhs
  • Net Profit after Tax: ₹204.66 lakhs
  • Profit After Tax attributed to: Owners of Parent ₹206.52 lakhs, Non-controlling Interest ₹(1.86) lakhs
  • Total Comprehensive Income: ₹204.66 lakhs
  • Basic and diluted EPS: ₹0.57 (not annualized)

Subsidiary Performance

Lyka BDR International Limited (subsidiary) contributed:

  • Total revenues: Nil for quarter ended June 30, 2026
  • Net loss after tax: ₹5.36 lakhs
  • Total comprehensive income: ₹(5.36) lakhs

Corporate Action: Subsidiary Divestment

The Board of Directors approved the proposal for divestment of 100% equity stake/investment held in subsidiary company Lyka BDR International Limited. The Audit Committee has been delegated authority to take necessary steps regarding:

  • Date of agreement execution
  • Expected completion date
  • Consideration amount
  • Buyer details
  • Related party transaction assessment
  • Arm's length nature determination

Financial Significance of Subsidiary

For financial year ended 31st March 2026:

  • Total Income: ₹1,055.48 lakhs (8% of consolidated income of the Company)
  • Net Worth: ₹(449.17) lakhs (negative)

The subsidiary is classified as non-material.

Historical Context

  • The National Company Law Tribunal (NCLT), Ahmedabad Bench sanctioned the Scheme of Amalgamation for merger of Lyka Export Limited with Lyka Labs Limited vide Order dated 16th March 2026
  • Accounting treatment given effect from date required under Ind AS 103 - Business Combinations
  • Figures have been restated for respective periods

Meeting Details

Board meeting held on 10th August 2026, commenced at 11:00 AM and concluded at 12:20 PM

Additional Information

  • Company operates in one business segment: Pharmaceuticals
  • Previous year figures have been restated/rearranged where necessary